133 related articles for article (PubMed ID: 18467331)
21. Development of a new anti-prolactin receptor (PRLR) antibody, F56, which can serve as a PRLR antagonist.
Cui H; Ma YZ; Wang Y; Song M; Zhang H
Int J Biol Macromol; 2017 Feb; 95():1223-1227. PubMed ID: 27829125
[TBL] [Abstract][Full Text] [Related]
22. Biological properties of human prolactin analogs depend not only on global hormone affinity, but also on the relative affinities of both receptor binding sites.
Kinet S; Bernichtein S; Kelly PA; Martial JA; Goffin V
J Biol Chem; 1999 Sep; 274(37):26033-43. PubMed ID: 10473550
[TBL] [Abstract][Full Text] [Related]
23. Threonine 391 phosphorylation of the human prolactin receptor mediates a novel interaction with 14-3-3 proteins.
Olayioye MA; Guthridge MA; Stomski FC; Lopez AF; Visvader JE; Lindeman GJ
J Biol Chem; 2003 Aug; 278(35):32929-35. PubMed ID: 12819209
[TBL] [Abstract][Full Text] [Related]
24. The tertiary structure and backbone dynamics of human prolactin.
Keeler C; Dannies PS; Hodsdon ME
J Mol Biol; 2003 May; 328(5):1105-21. PubMed ID: 12729745
[TBL] [Abstract][Full Text] [Related]
25. Prolactin signal transduction to milk protein genes: carboxy-terminal part of the prolactin receptor and its tyrosine phosphorylation are not obligatory for JAK2 and STAT5 activation.
Goupille O; Daniel N; Bignon C; Jolivet G; Djiane J
Mol Cell Endocrinol; 1997 Mar; 127(2):155-69. PubMed ID: 9099911
[TBL] [Abstract][Full Text] [Related]
26. Prolactin and its receptor as therapeutic targets in glioblastoma multiforme.
Asad AS; Nicola Candia AJ; Gonzalez N; Zuccato CF; Abt A; Orrillo SJ; Lastra Y; De Simone E; Boutillon F; Goffin V; Seilicovich A; Pisera DA; Ferraris MJ; Candolfi M
Sci Rep; 2019 Dec; 9(1):19578. PubMed ID: 31862900
[TBL] [Abstract][Full Text] [Related]
27. Homology modeling of rabbit prolactin hormone complexed with its receptor.
Halaby D; Thoreau E; Djiane J; Mornon JP
Proteins; 1997 Mar; 27(3):459-68. PubMed ID: 9094747
[TBL] [Abstract][Full Text] [Related]
28. Two independent histidines, one in human prolactin and one in its receptor, are critical for pH-dependent receptor recognition and activation.
Kulkarni MV; Tettamanzi MC; Murphy JW; Keeler C; Myszka DG; Chayen NE; Lolis EJ; Hodsdon ME
J Biol Chem; 2010 Dec; 285(49):38524-33. PubMed ID: 20889499
[TBL] [Abstract][Full Text] [Related]
29. Residue 146 regulates prolactin receptor folding, basal activity and ligand-responsiveness: potential implications in breast tumorigenesis.
Zhang C; Cherifi I; Nygaard M; Haxholm GW; Bogorad RL; Bernadet M; England P; Broutin I; Kragelund BB; Guidotti JE; Goffin V
Mol Cell Endocrinol; 2015 Feb; 401():173-88. PubMed ID: 25524456
[TBL] [Abstract][Full Text] [Related]
30. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation.
Endo T; Sasaki A; Minoguchi M; Joo A; Yoshimura A
J Biochem; 2003 Jan; 133(1):109-13. PubMed ID: 12761205
[TBL] [Abstract][Full Text] [Related]
31. Prolactin (PRL) and prolactin receptor (PRLR) genes and their role in poultry production traits.
Wilkanowska A; Mazurowski A; Mroczkowski S; Kokoszyński D
Folia Biol (Krakow); 2014; 62(1):1-8. PubMed ID: 24745142
[TBL] [Abstract][Full Text] [Related]
32. Evidence of rainbow trout prolactin interaction with its receptor through unstable homodimerisation.
Rouzic PL; Sandra O; Grosclaude J; Rentier-Delrue F; Jolois O; Tujague M; Pakdel F; Sandowski Y; Cohen Y; Gertler A; Prunet P
Mol Cell Endocrinol; 2001 Feb; 172(1-2):105-13. PubMed ID: 11165044
[TBL] [Abstract][Full Text] [Related]
33. Intramolecular disulfide bonds of the prolactin receptor short form are required for its inhibitory action on the function of the long form of the receptor.
Xie YL; Hassan SA; Qazi AM; Tsai-Morris CH; Dufau ML
Mol Cell Biol; 2009 May; 29(10):2546-55. PubMed ID: 19273600
[TBL] [Abstract][Full Text] [Related]
34. Development of pure prolactin receptor antagonists.
Bernichtein S; Kayser C; Dillner K; Moulin S; Kopchick JJ; Martial JA; Norstedt G; Isaksson O; Kelly PA; Goffin V
J Biol Chem; 2003 Sep; 278(38):35988-99. PubMed ID: 12824168
[TBL] [Abstract][Full Text] [Related]
35. The many faces of prolactin in breast cancer.
Chen WY
Adv Exp Med Biol; 2015; 846():61-81. PubMed ID: 25472534
[TBL] [Abstract][Full Text] [Related]
36. Thyrotropin-releasing hormone and oestrogen differentially regulate prolactin and prolactin receptor expression in female human skin and hair follicles in vitro.
Langan EA; Ramot Y; Hanning A; Poeggeler B; Bíró T; Gaspar E; Funk W; Griffiths CE; Paus R
Br J Dermatol; 2010 May; 162(5):1127-31. PubMed ID: 20302576
[TBL] [Abstract][Full Text] [Related]
37. Use of a model to understand prolactin and growth hormone specificities.
Goffin V; Martial JA; Summers NL
Protein Eng; 1995 Dec; 8(12):1215-31. PubMed ID: 8869634
[TBL] [Abstract][Full Text] [Related]
38. Prolactin is a component of the human synovial liquid and modulates the growth and chondrogenic differentiation of bone marrow-derived mesenchymal stem cells.
Ogueta S; Muñoz J; Obregon E; Delgado-Baeza E; García-Ruiz JP
Mol Cell Endocrinol; 2002 Apr; 190(1-2):51-63. PubMed ID: 11997178
[TBL] [Abstract][Full Text] [Related]
39. Identification of ligand binding determinants of the prolactin receptor.
Rozakis-Adcock M; Kelly PA
J Biol Chem; 1992 Apr; 267(11):7428-33. PubMed ID: 1559983
[TBL] [Abstract][Full Text] [Related]
40. Molecular evolution of prolactin in Chiroptera: Accelerated evolution and a large insertion in vespertilionid bats.
Wallis M
Gen Comp Endocrinol; 2018 Dec; 269():102-111. PubMed ID: 30172709
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
